Max Healthcare Institute Limited: NCLT Hearing Adjourned Until September 8, 2026
Max Healthcare Institute Limited is continuing the proceedings related to petitions filed by BRS Capital Two Pte. Limited against Kalinga Hospital Ltd. (KHL), a subsidiary of the Company, and the company itself. These matters stem from an earlier intimation dating back to August 7, 2026.The litigation involves BRS Capital Two Pte. Limited and concerns KHL, which is also a shareholder of the Company from whom Max Healthcare Institute Limited acquired its majority equity stake.
The matter was listed for hearing on August 19, 2026, before the National Company Law Tribunal (NCLT), Cuttack Bench. During the proceedings, the legal representatives representing BRS Capital Two Pte. Limited requested an adjournment of the case. The NCLT subsequently adjourned the hearing and scheduled a further hearing for September 8, 2026.
The status of the litigation confirms that it is not applicable in relation to any changes regarding key management personnel or the ultimate person in control. Additionally, no settlement of the proceedings has occurred.
MAXHEALTH Stock Price Movement
Shares of Max Healthcare Institute Limited slipped on Wednesday, closing at ₹997 after shedding ₹17.40 or 1.72%. The stock traded a total volume of 1.32 million shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.